These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A pilot study of HPV DNA and cytology testing in 50,159 women in the routine Mexican Social Security Program. Lazcano-Ponce E, Lörincz AT, Salmerón J, Fernández I, Cruz A, Hernández P, Mejia I, Hernández-Avila M. Cancer Causes Control; 2010 Oct; 21(10):1693-700. PubMed ID: 20617376 [Abstract] [Full Text] [Related]
7. HPV testing for cervical cancer screening appears more cost-effective than Papanicolau cytology in Mexico. Flores YN, Bishai DM, Lorincz A, Shah KV, Lazcano-Ponce E, Hernández M, Granados-García V, Pérez R, Salmerón J. Cancer Causes Control; 2011 Feb; 22(2):261-72. PubMed ID: 21170578 [Abstract] [Full Text] [Related]
8. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. Manos MM, Kinney WK, Hurley LB, Sherman ME, Shieh-Ngai J, Kurman RJ, Ransley JE, Fetterman BJ, Hartinger JS, McIntosh KM, Pawlick GF, Hiatt RA. JAMA; 1999 May 05; 281(17):1605-10. PubMed ID: 10235153 [Abstract] [Full Text] [Related]
9. Comparison of human papillomavirus DNA testing and repeat Papanicolaou test in women with low-grade cervical cytologic abnormalities: a randomized trial. HPV Effectiveness in Lowgrade Paps (HELP) Study No. 1 Group. Lytwyn A, Sellors JW, Mahony JB, Daya D, Chapman W, Ellis N, Roth P, Lorincz AT, Gafni A. CMAJ; 2000 Sep 19; 163(6):701-7. PubMed ID: 11022584 [Abstract] [Full Text] [Related]
11. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. Wright TC, Denny L, Kuhn L, Pollack A, Lorincz A. JAMA; 2000 Jan 05; 283(1):81-6. PubMed ID: 10632284 [Abstract] [Full Text] [Related]
12. Human papillomavirus (HPV) testing in the management of women with abnormal Pap smears. Experience of a colposcopy referral clinic. Ciotti M, Sesti F, Paba P, Benedetto A, Patrizi L, Criscuolo A, Piccione E, Branca M, Syrjänen K, Favalli C. Eur J Gynaecol Oncol; 2004 Jan 05; 25(5):577-84. PubMed ID: 15493169 [Abstract] [Full Text] [Related]
14. Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries? Bhatla N, Dar L, Patro AR, Kumar P, Kriplani A, Gulati A, Iyer VK, Mathur SR, Sreenivas V, Shah KV, Gravitt PE. Cancer Epidemiol; 2009 Dec 05; 33(6):446-50. PubMed ID: 19931499 [Abstract] [Full Text] [Related]
20. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds. C Kitchener H, Canfell K, Gilham C, Sargent A, Roberts C, Desai M, Peto J. Health Technol Assess; 2014 Apr 05; 18(23):1-196. PubMed ID: 24762804 [Abstract] [Full Text] [Related] Page: [Next] [New Search]